Sartoretto Verna™’s Post

Pharmacists Key to Digital Health Era The Digital Health Era, a new product from TINEXTRA's enhancers, enables us to observe the macro scenario of electronic health development. What interests are modern users developing? A detailed analysis of enhancers reveals a significant evolution. The macrosystem itself is driven by this evolution. In this context, the patient's home will increasingly become their primary point of care. The transition to this location is dependent on digital healthcare management, confidentiality, and mastery. There are times when traditional players assume a dominant role, particularly pharmaceutical companies. These companies employ pharmacists who can interpret patients' needs, decode their requirements, and provide adequate responses based on professional competence and appropriateness. In modern times, digital electronic health is an unmistakable and inescapable appointment, which will be reached by all modern citizens. Therefore, adapting the pharmacist's role is an absolute necessity.

𝗜𝗩 𝗜𝗻𝗳𝘂𝘀𝗶𝗼𝗻 𝗦𝗲𝘁 𝗠𝗮𝗿𝗸𝗲𝘁 𝟮𝟬𝟮𝟰-𝟮𝟬𝟯𝟭. 𝗚𝗹𝗼𝗯𝗮𝗹 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗥𝗲𝗽𝗼𝗿𝘁 This report presents a detailed and comprehensive analysis of the global IV Infusion Set market, offering both quantitative and qualitative insights categorized by manufacturers, regions & countries, types, and applications. It examines the ever-evolving landscape of the market, exploring competition, supply and demand trends, and key factors influencing changing demands across multiple markets. The report includes company profiles and product examples of selected competitors, along with market share estimates for the year 2024. The IV Infusion Set market is segmented by type and application, providing accurate calculations and forecasts for consumption value by both parameters from 2024 to 2031. This analysis serves as a valuable tool for businesses seeking to expand by targeting specific niche markets. 𝗧𝗼 𝗞𝗻𝗼𝘄 𝗚𝗹𝗼𝗯𝗮𝗹 𝗦𝗰𝗼𝗽𝗲 𝗮𝗻𝗱 𝗗𝗲𝗺𝗮𝗻𝗱 𝗼𝗳 𝗜𝗩 𝗜𝗻𝗳𝘂𝘀𝗶𝗼𝗻 𝗦𝗲𝘁 𝗠𝗮𝗿𝗸𝗲𝘁. 𝗥𝗲𝗾𝘂𝗲𝘀𝘁 𝗳𝗼𝗿 𝗦𝗮𝗺𝗽𝗹𝗲 𝗣𝗗𝗙: https://lnkd.in/dN4-HtBM *𝗕𝘆 𝗧𝘆𝗽𝗲: Filtered IV Sets, Vented IV Sets, Non-Vented IV Sets, Gravity Tubing *𝗕𝘆 𝗔𝗽𝗽𝗹𝗶𝗰𝗮𝘁𝗶𝗼𝗻: Hospitals, Clinics, Others *𝗕𝘆 𝗥𝗲𝗴𝗶𝗼𝗻: North America, Europe, Asia-Pacific, South America, Middle East & Africa *𝗕𝘆 𝗞𝗲𝘆 𝗣𝗹𝗮𝘆𝗲𝗿𝘀: Vitrex Medical A/S, Micrel Medical Devices, Sunrise Medical , Int'Air Medical, Kapsam, Nanjing Shuangwei Biotechnology Co.,Ltd., GenSci , Baihe Medical Technology, Zhejiang Runqiang Medical Instruments Co., Ltd, Baxter International Inc., Nipro Medical Corporation, B. Braun Medical Inc. (US), Lily Medical Group, ANGIPLAST PVT. LTD. (INDIA), Nishi Medcare #ivinfusionset #medicaldevices #healthcare #intravenous #infusiontherapy #hospitalcare #healthtech #nursing #patientcare #medicalsupplies #ivtherapy #healthandwellness #ivtreatment #healthinnovation #clinicalcare #medicaltechnology #nursingcare #healthprofessionals #intravenousfluids #healthmanagement #ivdrip #ivcare #nursinginnovation #medicalprocedure #intravenousaccess #nursingpractice #healthindustry #medicaldeviceindustry #ivadministration #healthcareproviders

𝗜𝗩 𝗜𝗻𝗳𝘂𝘀𝗶𝗼𝗻 𝗦𝗲𝘁 𝗠𝗮𝗿𝗸𝗲𝘁 𝟮𝟬𝟮𝟰-𝟮𝟬𝟯𝟭. 𝗚𝗹𝗼𝗯𝗮𝗹 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗥𝗲𝗽𝗼𝗿𝘁 This report presents a detailed and comprehensive analysis of the global IV Infusion Set market, offering both quantitative and qualitative insights categorized by manufacturers, regions & countries, types, and applications. It examines the ever-evolving landscape of the market, exploring competition, supply and demand trends, and key factors influencing changing demands across multiple markets. The report includes company profiles and product examples of selected competitors, along with market share estimates for the year 2024. The IV Infusion Set market is segmented by type and application, providing accurate calculations and forecasts for consumption value by both parameters from 2024 to 2031. This analysis serves as a valuable tool for businesses seeking to expand by targeting specific niche markets. 𝗧𝗼 𝗞𝗻𝗼𝘄 𝗚𝗹𝗼𝗯𝗮𝗹 𝗦𝗰𝗼𝗽𝗲 𝗮𝗻𝗱 𝗗𝗲𝗺𝗮𝗻𝗱 𝗼𝗳 𝗜𝗩 𝗜𝗻𝗳𝘂𝘀𝗶𝗼𝗻 𝗦𝗲𝘁 𝗠𝗮𝗿𝗸𝗲𝘁. 𝗥𝗲𝗾𝘂𝗲𝘀𝘁 𝗳𝗼𝗿 𝗦𝗮𝗺𝗽𝗹𝗲 𝗣𝗗𝗙: https://lnkd.in/dN4-HtBM *𝗕𝘆 𝗧𝘆𝗽𝗲: Filtered IV Sets, Vented IV Sets, Non-Vented IV Sets, Gravity Tubing *𝗕𝘆 𝗔𝗽𝗽𝗹𝗶𝗰𝗮𝘁𝗶𝗼𝗻: Hospitals, Clinics, Others *𝗕𝘆 𝗥𝗲𝗴𝗶𝗼𝗻: North America, Europe, Asia-Pacific, South America, Middle East & Africa *𝗕𝘆 𝗞𝗲𝘆 𝗣𝗹𝗮𝘆𝗲𝗿𝘀: Vitrex Medical A/S, Micrel Medical Devices, Sunrise Medical , Int'Air Medical, Kapsam, Nanjing Shuangwei Biotechnology Co.,Ltd., GenSci , Baihe Medical Technology, Zhejiang Runqiang Medical Instruments Co., Ltd, Baxter International Inc., Nipro Medical Corporation, B. Braun Medical Inc. (US), Lily Medical Group, ANGIPLAST PVT. LTD. (INDIA), Nishi Medcare #ivinfusionset #medicaldevices #healthcare #intravenous #infusiontherapy #hospitalcare #healthtech #nursing #patientcare #medicalsupplies #ivtherapy #healthandwellness #ivtreatment #healthinnovation #clinicalcare #medicaltechnology #nursingcare #healthprofessionals #intravenousfluids #healthmanagement #ivdrip #ivcare #nursinginnovation #medicalprocedure #intravenousaccess #nursingpractice #healthindustry #medicaldeviceindustry #ivadministration #healthcareproviders

𝗜𝗩 𝗜𝗻𝗳𝘂𝘀𝗶𝗼𝗻 𝗦𝗲𝘁 𝗠𝗮𝗿𝗸𝗲𝘁 𝟮𝟬𝟮𝟰-𝟮𝟬𝟯𝟭. 𝗚𝗹𝗼𝗯𝗮𝗹 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗥𝗲𝗽𝗼𝗿𝘁 This report presents a detailed and comprehensive analysis of the global IV Infusion Set market, offering both quantitative and qualitative insights categorized by manufacturers, regions & countries, types, and applications. It examines the ever-evolving landscape of the market, exploring competition, supply and demand trends, and key factors influencing changing demands across multiple markets. The report includes company profiles and product examples of selected competitors, along with market share estimates for the year 2024. The IV Infusion Set market is segmented by type and application, providing accurate calculations and forecasts for consumption value by both parameters from 2024 to 2031. This analysis serves as a valuable tool for businesses seeking to expand by targeting specific niche markets. 𝗧𝗼 𝗞𝗻𝗼𝘄 𝗚𝗹𝗼𝗯𝗮𝗹 𝗦𝗰𝗼𝗽𝗲 𝗮𝗻𝗱 𝗗𝗲𝗺𝗮𝗻𝗱 𝗼𝗳 𝗜𝗩 𝗜𝗻𝗳𝘂𝘀𝗶𝗼𝗻 𝗦𝗲𝘁 𝗠𝗮𝗿𝗸𝗲𝘁. 𝗥𝗲𝗾𝘂𝗲𝘀𝘁 𝗳𝗼𝗿 𝗦𝗮𝗺𝗽𝗹𝗲 𝗣𝗗𝗙: https://lnkd.in/dN4-HtBM *𝗕𝘆 𝗧𝘆𝗽𝗲: Filtered IV Sets, Vented IV Sets, Non-Vented IV Sets, Gravity Tubing *𝗕𝘆 𝗔𝗽𝗽𝗹𝗶𝗰𝗮𝘁𝗶𝗼𝗻: Hospitals, Clinics, Others *𝗕𝘆 𝗥𝗲𝗴𝗶𝗼𝗻: North America, Europe, Asia-Pacific, South America, Middle East & Africa *𝗕𝘆 𝗞𝗲𝘆 𝗣𝗹𝗮𝘆𝗲𝗿𝘀: Vitrex Medical A/S, Micrel Medical Devices, Sunrise Medical , Int'Air Medical, Kapsam, Nanjing Shuangwei Biotechnology Co.,Ltd., GenSci , Baihe Medical Technology, Zhejiang Runqiang Medical Instruments Co., Ltd, Baxter International Inc., Nipro Medical Corporation, B. Braun Medical Inc. (US), Lily Medical Group, ANGIPLAST PVT. LTD. (INDIA), Nishi Medcare #ivinfusionset #medicaldevices #healthcare #intravenous #infusiontherapy #hospitalcare #healthtech #nursing #patientcare #medicalsupplies #ivtherapy #healthandwellness #ivtreatment #healthinnovation #clinicalcare #medicaltechnology #nursingcare #healthprofessionals #intravenousfluids #healthmanagement #ivdrip #ivcare #nursinginnovation #medicalprocedure #intravenousaccess #nursingpractice #healthindustry #medicaldeviceindustry #ivadministration #healthcareproviders

Uncovering Hidden Costs in nAMD Clinics In the quest for cost-effectiveness, are we missing a crucial piece of the puzzle? Our latest publication "Real-world service costs for neovascular-AMD clinics in the United Kingdom: Structured literature review and scenario analysis" published in Current Medical Research and Opinion, reveals the significant strain costs impacting nAMD clinics, often overlooked in traditional cost-effectiveness analyses. In our scenario analysis, Drug A may appear cheaper with a lower upfront cost (£10), the associated strain costs (£13,115) paint a different picture compared to Drug B (£100 upfront with no additional strain costs). What does this mean? • Drug A: Lower initial cost but significant long-term strain costs. • Drug B: Higher initial cost but no additional strain costs. Impact on Decision-Making: When evaluating options, it's essential to consider not just the drug costs, but also the broader economic impact on the service as a whole. Incorporating strain costs into Health Technology Assessments (HTA) provides a more comprehensive view, ensuring sustainable and efficient healthcare delivery. Get in touch with Medialis Ltd at info@medialis.co.uk to help shift your focus to more holistic evaluations that account for all costs, fostering better decision-making and improved patient care. Join the conversation and share your insights on how we can better integrate these findings into our practices. #nAMD #HealthcareEconomics #CostEffectiveness #HTA #HealthcareInnovation #DiseaseSpecific #CostInstrument #nASInstrument

Medical Science Liaisons (#MSLs) bridge scientific innovation and healthcare delivery, driving advancements that improve patient outcomes. In this latest article, we explore MSLs' pivotal roles and responsibilities, their engagement with #KOLs, and how digital transformation shapes their work. Discover their key challenges and how their expertise redefines the #healthcare landscape. https://bit.ly/3BxlJuC #MedicalScienceLiaisons #ThoughtLeaders #konectar #HealthcareProfessionals

Uncovering Hidden Costs in nAMD Clinics   In the quest for cost-effectiveness, are we missing a crucial piece of the puzzle?    Our latest publication "Real-world service costs for neovascular-AMD clinics in the United Kingdom: Structured literature review and scenario analysis" published in Current Medical Research and Opinion, reveals the significant strain costs impacting nAMD clinics, often overlooked in traditional cost-effectiveness analyses.    In our scenario analysis, Drug A may appear cheaper with a lower upfront cost (£10), the associated strain costs (£13,115) paint a different picture compared to Drug B (£100 upfront with no additional strain costs).   What does this mean? • Drug A: Lower initial cost but significant long-term strain costs. • Drug B: Higher initial cost but no additional strain costs. Impact on Decision-Making: When evaluating options, it's essential to consider not just the drug costs but also the broader economic impact on the service as a whole. Incorporating strain costs into Health Technology Assessments (HTA) provides a more comprehensive view, ensuring sustainable and efficient healthcare delivery.   Get in touch with Medialis Ltd to help shift your focus to more holistic evaluations that account for all costs, fostering better decision-making and improved patient care. Join the conversation and share your insights on how we can better integrate these findings into our practices.   #nAMD #HealthcareEconomics #CostEffectiveness #HTA #HealthcareInnovation #PatientCare

Good morning all. Unless we see the full picture, we will miss important information, making our decisions flawed. This is happening every day, in all walks of life, sadly. In this example, we at Medialis Ltd have demonstrated how operationalising my #Neutraltheory via #jandhyalamethod can 'flip' the script and correct the answer to the question: 'Which drug is the cheapest option?' There is simply NO downside to doing this work. Get in touch on info@medialis.co.uk to protect your patients from flawed research. #medicalaffairs #marketaccess #pharmaceuticals

🔍 Guiding Principles for Medical Device Health Equity 🔍 📄 Published by: With IMDRF in #GlobalHealth, 8 February 2024. 🔺 Background: Health equity entails addressing avoidable health differences among populations. The IMDRF recognizes the impact of biological, economic, and social factors on health outcomes, fostering discussions to promote equity. 🔺 Age, Sex, Gender, Ethnicity, Race, Socio-economic status: These factors contribute to health disparities. While age influences health experiences, sex and gender entail biological and societal roles. Ethnicity and race denote cultural identity, while socio-economic status signifies financial and social conditions. 🔺 Guiding Principles: IMDRF advocates incorporating health equity considerations throughout medical device development and regulation. 💡 Recognize and Address Health Equity: Encourage inclusive approaches in technical document drafting. 💡Disaggregated Data Relevance: Analyze data across subcategories to understand device performance among diverse populations. 💡Identify Differential Impacts: Assess how devices affect various subgroups, considering anatomical, physiological, and access differences. ℹ️ Relevance: Understanding and implementing these principles are crucial in ensuring medical devices cater to diverse population needs, promoting equitable healthcare outcomes. More information: https://lnkd.in/gTUj9PNC #pharma #pharmout #pharmaceutical #healthcareequity

Navigating the Complexities of Global Healthcare Supply Chains 🌍 In a world where medical supply chains have become increasingly internationalized, the challenges facing the healthcare industry are more complex than ever before. Recent insights from the OECD shed light on the intricate nature of these supply chains, particularly in the pharmaceutical and medical device sectors. Understanding Supply Chain Dynamics: Medical supply chains encompass the entire journey of goods and services, from production to distribution, and ultimately to the end-user – be it patients, healthcare professionals, or institutions. The production of medicines and medical devices involves a myriad of steps, with global trade in pharmaceuticals and medical devices having increased significantly over the past few decades. Addressing Shortages and Resilience: Prior to the COVID-19 pandemic, shortages of essential medicines and medical devices were already widespread, with manufacturing and quality issues often cited as root causes. Despite these challenges, medical product supply chains have demonstrated considerable resilience, particularly in the face of crises such as the H1N1 and COVID-19 pandemics. The Role of Innovation: Encode Health recognizes the critical importance of resilient and efficient medical supply chains. Our innovative platform leverages advanced technologies to streamline inventory processes, optimize stock levels, and ensure seamless supply chain operations. By empowering healthcare providers with real-time insights and automated solutions, we aim to enhance patient safety and improve healthcare outcomes. Looking Ahead: As we navigate the complexities of global healthcare supply chains, Encode Health remains committed to driving positive change in the industry. Our aspiration is to continue innovating and collaborating with stakeholders across the healthcare ecosystem to build a more resilient and sustainable future for all. Together, let us forge ahead on this journey towards better healthcare for everyone. #HealthcareSupplyChains #GlobalHealthcare #EncodeHealth